Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Retina > Top Videos: Innovations in Glaucoma, Retinal Disease, and Demodex Blepharitis Treatment
  • Retina

Top Videos: Innovations in Glaucoma, Retinal Disease, and Demodex Blepharitis Treatment

Kelsey Moroz

Videos explored the latest advancements in eye care as leading experts discuss groundbreaking treatments for glaucoma, retinal diseases, and Demodex blepharitis, including minimally invasive surgeries, non-invasive diagnostics, and new therapies for vision preservation.

 

1. Navigating the Management and Treatment of Demodex Blepharitis

Demodex blepharitis, caused by mites living at the base of the eyelashes, leads to symptoms like itching, erythema, and irritation along the eyelid, which significantly impact a patient’s quality of life. In this video, Dr Eric Donnenfeld and Dr. Preeya Gupta discuss recent advancements, such as the use of lotilaner ophthalmic solution, in treating this condition by eradicating the mites and providing long-term relief for patients.

Watch now

 

2. Roundtable Discussion: The unmet need in standalone glaucoma treatment

Drs. Mehul Nagarsheth, Alex Gerber, and Valerie Trubnik, discuss the advancements in glaucoma treatment, highlighting the recent surge in minimally invasive glaucoma surgeries (MIGS) and new devices, such as the FDA-approved iStent Infinite. The conversation touches on the evolving approach to glaucoma care, with a shift toward earlier surgical intervention and the potential benefits of standalone MIGS for patients across various stages of the disease.

Watch now

 

3. The evidence supporting earlier glaucoma intervention

Drs. Manjool Shah, Christine Funke, and Inder Paul Singh discuss the growing evidence supporting earlier intervention in glaucoma management to prevent irreversible vision loss. They highlight various studies that suggest treating glaucoma earlier can help preserve vision and improve long-term patient outcomes, stressing the need for proactive monitoring and treatment strategies.

Watch now

 

4. Geographic Atrophy Treatment Landscape: Insights From Mitul Mehta, MD

In this video, Dr. Mitul Mehta talks about the evolving treatment landscape for geographic atrophy (GA) in age-related macular degeneration. It emphasizes the potential of emerging therapies, including complement inhibitors, and the importance of early diagnosis and personalized treatment strategies to slow GA progression and preserve vision.

Watch now

 

5. Medication-First Approach for Glaucoma

In this video, Dr. Manjool Shah, moderates a conversation with Dr. Tosin Smith and DR. David Stephens, on the evolution of treatment and management of glaucoma, with an emphasis on where medications, especially, topical medications, fit into the treatment armamentarium.

Watch Now

Share

Related Content

  • Retina

Switching to aflibercept 8 mg improved anatomical outcomes in previously treated nAMD

  • Glaucoma

EyeValve device lowers IOP and maintains control for 9 months in first-in-human study

  • Glaucoma

GLP-1 therapies may offer potential benefits in glaucoma

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency
  • Retina

Treat-and-extend aflibercept 8 mg improves outcomes in nAMD over 1 year

  • Retina

Intravitreal therapy in nAMD linked to lower depression and anxiety risk

  • Glaucoma

PreserFlo MicroShunt shows short-term benefit in refractory childhood glaucoma

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon